HALO Sale Disclosure
Torley Helen · SEC Form 4 · Filed Oct 8, 2026
Sale
Calculated transaction value
$22.1K
Torley Helen President And CEO
HALO
Transaction date
Oct 8, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed same day
HALO daily price context
Close on/before transaction
$109.98
Oct 8, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 200 shares @ $110.51
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000140
Filing cohort
Transactions in this filing
Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$8.82M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 8, 2026 | $520.34K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Oct 8, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 8, 2026 | $1.31M |
| Halozyme Therapeutics, Inc. HALO | Exercise | Oct 8, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO Current | Sale | Oct 8, 2026 | $22.1K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 8, 2026 | $336.53K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Oct 7, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Oct 7, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 7, 2026 | $954.87K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 7, 2026 | $1.15M |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 7, 2026 | $22.74K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 7, 2026 | $101.5K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 6, 2026 | $1.09M |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 6, 2026 | $656K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 6, 2026 | $197.25K |